The trademark EPISTAR was filed by Amphastar Pharmaceuticals, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on March 17, 2021, and received one opposition filed on April 8, 2021 by Mylan Inc. on Likelihood of confusion. the opponent was represented by DF-MP DÖRRIES FRANK-MOLNIA & POHLMAN PATENTANWÄLTE RECHTSANWÄLTE PARTG MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued April 8, 2021
The application was filed in Swedish, and Swedish was also language of all opposition proceedings (English was selected as the second language).
Change of name and professional address of the trademark registration was recorded on April 11, 2021.